Vitiligo in Different Ethnicities
Clinicians should strive to address the unique medical and aesthetic challenges seen in vitiligo.
Uncombable Hair Syndrome: How to Identify and Help Children With this Rare Disorder
Uncombable hair syndrome (UHS) can cause distress for families, but dermatologists can help with the rare genetic disease diagnosis and management.
Rosacea and Menopause
A recent study published in Clinical and Experimental Dermatology observed a link between menopause and rosacea and found that menopausal flushing can exacerbate and precipitate rosacea.
Nonsteroidal Treatment Options for Plaque Psoriasis
Linda Stein Gold, MD, and Jennifer Soung, MD, discuss available nonsteroidal treatment options for plaque psoriasis in this DermView series recap.
An Overview of Documented Flares in Patients With GPP
Aaron Farberg, MD, and Jeffrey Crowley, MD, take a closer look at the management and treatment of generalized pustular psoriasis.
Equity Indexed Life Insurance Policies and Structured Notes: Asset Classes With Principal Protection and Growth Potential
This article reviews equity-indexed life insurance policies and structured notes, instruments that offer investment protection and growth potential.
The Art of Smelling Good
In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, discusses fragrances in skin care products.
Losing a Malpractice Case May Depend on Where You Live
This month's Legal Eagle column explores what information is required during an informed consent discussion.
The Role We Play in Addressing Racial Disparity in Dermatology
It’s important to continuously look forward to our role in serving all patients and colleagues—especially those who are underrepresented.
Pemphigus: Updated Review and Emerging Therapies
Pemphigus is defined as a group of autoimmune, blistering disorders caused by circulating autoantibodies that bind to desmogleins, proteins that are vital to epidermal intercellular adhesion.
Harnessing the Immune System to Fight Basal Cell Carcinoma: What are the Risks?
In basal cell carcinoma, the most common type of skin cancer accounting for 80% of all non-melanoma skin cancers, one of the leading options for cases that fall into this category is targeted treatment with Hedgehog pathway inhibitors.
Treatment and Diagnosis of Merkel Cell Disease
Although Merkel cell carcinoma can develop undetected or at a metastasized site, it usually first appears as a painless lump or nodule on an area of the skin that has been exposed to the sun.
Phase 2 Clinical Trial of Synthetic Hypericin Underway for Treatment of Mild-to-Moderate Psoriasis
Patient enrollment is now open for the study conducted by late-stage biopharmaceutical company, Soligenix.
Digital Dermatology: Opportunities for Atopic Dermatitis
At the RAD 2022 Conference, Steve Xu, MD, MSc, explains how a wearable sensor can better track the progression of atopic dermatitis while a patient is sleeping.
Updates on Topical Therapy Treatment for AD
Jonathan Silverberg, MD, PhD, MPHS, gives an overview of topical therapies for atopic dermatitis at the 2022 virtual RAD conference.
The Shades of Atopic Dermatitis in Skin of Color
At the 2022 RAD virtual conference, a dermatologist examines treatment options for AD in various racial and ethnic groups.
Boston Children’s Multidisciplinary Clinic’s Model for Adverse Mental Health Effects of AD
At the 2022 RAD Conference, a Harvard University psychologist discusses ways that practitioners can help identify and treat children with adverse mental health outcomes as a result of atopic dermatitis.
An Overview of Argyria
Argyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.
2 Clarke Drive Cranbury, NJ 08512